...
首页> 外文期刊>Gut: Journal of the British Society of Gastroenterology >Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis
【24h】

Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis

机译:定期内镜扩张对初级硬化性胆管炎患者疗效的疗效的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Scheduled endoscopic dilatation of dominant strictures (DS) in primary sclerosing cholangitis (PSC) might improve outcome relative to endoscopic treatment on demand, but evidence is limited. Since randomisation is difficult in clinical practice, we present a large retrospective study comparing scheduled versus on-demand endoscopic retrograde cholangiopancreatography (ERCP) based on patient preferences.Between 1987 and 2017, all new patients with PSC had been offered scheduled ERCP with dilatation of a DS if diagnosed; the latter was repeated at defined intervals until morphological resolution, independent of clinical symptoms (treatment group). Patients who refused participation were clinically evaluated annually and received endoscopic treatment only on demand (control group). The primary clinical endpoint was transplantation-free survival. Secondary outcomes were overall survival, bacterial cholangitis episodes, hepatic decompensation of liver cirrhosis and endoscopy-related adverse events.The final study included 286 patients, 133 (46.5%) receiving scheduled ERCP and 153 (53.5%) receiving on-demand ERCP. After a mean follow-up of 9.9 years, the rate of transplantation-free survival was higher in patients receiving scheduled ERCP (51% vs 29.3%; p<0.001), as was transplantation-free survival time (median: 17.9 vs 15.2 years; log-rank: p=0.008). However, the benefit of scheduled ERCP was significant only in patients with the initial (17.1%) or later (45.5%) diagnosis of a DS (17.8 vs 11.1 years; log-rank: p<0.001). IBD (p=0.03), DS (p=0.006), higher Mayo Risk Score (p=0.02) and non-adherence to scheduled endoscopy (p=0.005) were independently associated with transplantation-free survival.In our large retrospective study, regular ERCP with endoscopic balloon dilatation significantly benefits patients with PSC with DS, diagnosed both at initial presentation and during surveillance, even if asymptomatic. Further studies have to find out how to best identify stricture patients non-invasively.
机译:预定的内镜分扩张在原发性硬化胆管炎(PSC)中的主导狭窄(DS)可能会改善相对于内窥镜治疗的结果,但证据有限。由于随机化在临床实践中困难,我们提出了一个大型回顾性研究,比较计划与患者偏好的调度与点心内窥镜逆行胆管痴呆胆管术(ERCP)。1987年和2017年,所有新的PSC患者都已提供预定的ERCP,并扩张了一个DS如果诊断;后者以定义的间隔重复,直至形态分辨率,与临床症状无关(治疗组)。拒绝参与的患者每年临床评估,并仅根据需要(对照组)进行内窥镜治疗。主要临床终点是无移植的存活。二次结果是整体存活,细菌胆管炎发作,肝硬化和内窥镜检查相关不良事件的肝脏失代组。最后研究包括286名患者,133名(46.5%)接受预定的ERCP和153名(53.5%)接受按需ERCP。在99年的平均随访后,接受预定的ERCP患者的移植存活率较高(51%与29.3%; P <0.001),如移植存活时间(中位数:17.9 Vs 15.2岁;日志排名:p = 0.008)。然而,预定的ERCP的益处仅在初始(17.1%)或后期(45.5%)诊断的患者中(17.8 vs 11.1年; log-ange:p <0.001)。 IBD(P = 0.03),DS(P = 0.006),较高的MASO风险评分(P = 0.02)和不粘附到预定的内窥镜检查(P = 0.005)与无移植的存活有关。在我们的大型回顾性研究中,具有内窥镜球囊扩张的常规ERCP显着益处PSC与DS的患者,在初始呈现和监测期间诊断,即使是无症状的。进一步的研究必须了解如何最好地识别狭窄患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号